Additional Indications Approved
- Posted By Seksyen Koordinasi Regulatori Produk & Kosmetik
- Hits: 179933
Year 2026
| DCA423 |
| DCA422 |
| DCA421 |
| DCA420 |
| DCA419 |
| DCA418 |
| DCA417 |
| DCA416 |
Year 2025
| DCA415 |
| DCA414 |
| DCA413 |
| DCA412 |
| DCA411 |
| DCA410 |
| DCA409 |
| DCA408 |
| DCA407 |
| DCA406 |
| DCA405 |
| DCA404 |
Year 2024
| DCA403 |
| DCA402 |
| DCA401 |
| DCA400 |
| DCA399 |
| DCA398 |
| DCA397 |
| DCA396 |
| DCA395 |
| DCA394 |
| DCA393 |
| DCA392 |
Year 2023
| DCA391 |
| DCA390 |
| DCA389 |
| DCA388 |
| DCA387 |
| DCA386 |
| DCA385 |
| DCA384 |
| DCA383 |
| DCA382 |
| DCA381 |
| DCA380 |
Year 2022
| DCA379 |
| DCA378 |
| DCA377 |
| DCA376 |
| DCA375 |
| DCA374 |
| DCA373 |
| DCA372 |
| DCA371 |
| DCA370 |
| DCA369 |
| DCA368 |
Year 2021
| DCA367 |
| DCA366 |
| DCA365 |
| DCA363 |
| DCA362 |
| DCA361 |
| DCA360 |
| DCA359 |
| DCA358 |
| DCA357 |
| DCA356 |
| DCA355 |
| DCA354 |
| DCA353 |
| DCA352 |
Year 2020
| DCA351 |
| DCA350 |
| DCA349 |
| DCA348 |
| DCA347 |
| DCA346 |
| DCA345 |
| DCA344 |
| DCA343 |
| DCA342 |
Year 2019
| DCA341 |
| DCA340 |
| DCA339 |
| DCA338 |
| DCA337 |
| DCA336 |
| DCA335 |
| DCA334 |
| DCA333 |
| DCA332 |
| DCA331 |
| DCA330 |
Year 2018
| DCA329 |
| DCA328 |
| DCA327 |
| DCA326 |
| DCA325 |
| DCA324 |
| DCA323 |
| DCA322 |
| DCA321 |
| DCA320 |
| DCA319 |
| DCA319 Manual |
Year 2017
| DCA318 |
| DCA318 (Manual) |
| DCA317 |
| DCA316 |
| DCA315 |
| DCA314 |
| DCA313 |
| DCA312 |
| DCA311 |
| DCA310 |
| DCA309 |
| DCA308 |
| Date | |
| Biosimilars Approved |
6th Aug 2026 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.